Atlas Trials

Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis

Clinical trial NCT00607581 · COMPLETED

Trial details

NCT number
NCT00607581
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Amyloidosis
Start date
2008-02-01
Primary completion
2011-12-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.